U.S. markets open in 4 hours 12 minutes
  • S&P Futures

    4,619.25
    +53.00 (+1.16%)
     
  • Dow Futures

    34,751.00
    +294.00 (+0.85%)
     
  • Nasdaq Futures

    16,370.25
    +219.75 (+1.36%)
     
  • Russell 2000 Futures

    2,244.40
    +47.10 (+2.14%)
     
  • Crude Oil

    69.02
    +2.84 (+4.29%)
     
  • Gold

    1,784.30
    +7.80 (+0.44%)
     
  • Silver

    22.91
    +0.09 (+0.39%)
     
  • EUR/USD

    1.1337
    -0.0003 (-0.02%)
     
  • 10-Yr Bond

    1.4430
    0.0000 (0.00%)
     
  • Vix

    23.74
    +0.78 (+3.40%)
     
  • GBP/USD

    1.3320
    +0.0018 (+0.14%)
     
  • USD/JPY

    113.4100
    +0.2300 (+0.20%)
     
  • BTC-USD

    57,072.11
    +311.72 (+0.55%)
     
  • CMC Crypto 200

    1,469.89
    +27.12 (+1.88%)
     
  • FTSE 100

    7,158.03
    +98.58 (+1.40%)
     
  • Nikkei 225

    27,935.62
    +113.86 (+0.41%)
     

Biogen Stock Drops as ALS Trial Fails. Ionis Is Getting Hit Even Harder.

·3 min read
Biogen Stock Drops as ALS Trial Fails. Ionis Is Getting Hit Even Harder.
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Shares of the biotech companies are slumping after the failure of a trial for its treatment for amyotrophic lateral sclerosis.